InterpretOmics

Bengaluru, India Founded: 2009 • Age: 17 yrs Minicorn
Cloud-based software is provided for genome data analysis and interpretation.

About InterpretOmics

InterpretOmics is a Healthcare company based in Bengaluru (India) founded in 2009 by Amrith Prasad and Archana Prahlad. Cloud-based software is provided for genome data analysis and interpretation. InterpretOmics has raised $1.92 million across 2 funding rounds from investors including Amarante Shipping, Somaprasad Muttael Prabhakaran and Prashant Priya. The company has 56 employees. InterpretOmics was last valued at $7.33 million in January 2017. Its Indian entity Interpretomics India Private Limited reported revenue of β‚Ή1.20 Cr. InterpretOmics offers products and services including ELISA Kits, Recombinant Proteins, and Expression Vectors. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified.

Company details

InterpretOmics is an integrated genomics company providing genome-scale data analysis and interpretation product and services. The company utilizes public and proprietary databases to analyze data and interpret results. Its enterprise level genomics data analysis platform iOMICS allows researchers to analyze DNA and identify diagnostic markers that indicate disease. Omnia is a platform which provides users access to genetic data sets across a board range of disease indications. The company has also introduced GeneComplete is an NGS-based genetic test to confirm or determine the presence of disease in an individual, suspected of having a disease. It is also working on Preimplantation genetic screening (PGS) - a microarray-based powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities and Hotspot Cancer Mutation Screening. The company also offers genetic counseling services under the umbrella of AlphaLife using genetic and biochemical tests. It has processed about 35 TB of genomics data over 40 projects for clients including Delaware State University (DSU) and AIIMS. Singapore-based shipping company, Amarante is an investor in the company.

  • Headquarters Bengaluru, India
  • Employees 56
  • Founders Amrith Prasad, Archana Prahlad
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website interpretomics.co
  • Social LinkedIn X Facebook
  • Legal Name Interpretomics India Private Limited
  • Date of Incorporation 05 Dec, 2007
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹1.20 Cr

    FY 2016 · +52% YoY

  • Net Loss
    -₹5.37 Cr

    FY 2016 · -446% margin

  • EBITDA
    -₹4.60 Cr

    FY 2016 · -382% margin

  • Total Equity Funding
    $1.92M (USD)

    in 2 rounds

  • Latest Funding Round
    $293.14K (USD), Seed

    Jan 2017

  • Investors
  • Employee Count
    56

Products & Services of InterpretOmics

InterpretOmics offers a comprehensive portfolio of products and services, including ELISA Kits, Recombinant Proteins, and Expression Vectors.

ELISA Kits
Diagnostic Tools

Kits for antigen detection in molecular research

Recombinant Proteins
Biotech Products

Proteins for cloning and expression in biology

Expression Vectors
Genetic Tools

Vectors for rapid DNA cloning and protein purification

Funding Insights of InterpretOmics

InterpretOmics has successfully raised a total of $1.92M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $293.14 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.92M
  • Total Rounds 2
  • Last Round Seed β€” $293,140
  • First Round $1.63M

    (Aug 2013)

  • Investors Count 3

All 2 funding rounds of InterpretOmics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2017$293,140Seed$7.33MAmarante Shipping
Aug 2013$1.63MSeed$8MAmarante Shipping
Valuation history
DateValuationStage
Jan 2017$7.33Mβ€’β€’β€’β€’β€’β€’β€’β€’
Aug 2013$8Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $7.33M (Jan 2017). 3 investors in total: 1 institutional and 2 angel.

Investors in InterpretOmics

InterpretOmics has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Amarante Shipping, Somaprasad Muttael Prabhakaran and Prashant Priya.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Global provider of bulk cargo shipping, trading, and vessel operations services.
amarante.com.sgSingapore, Singapore

Somaprasad Muttael Prabhakaran

unknown_a0da2eab52bc4a99b

Prashant Priya

unknown_32d1ecfdc7404aa08
Premium access

Investor details for InterpretOmics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Interpretomics India Private Limited (InterpretOmics)

Interpretomics India Private Limited is the primary company behind InterpretOmics. The board of Interpretomics India Private Limited currently have 5 directors; the longest-serving is Prahalad Haldhoderi Achutharao, appointed in 2007. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Prahalad Haldhoderi Achutharao
DIN 01804791
Managing Director05 Dec 200718 yrs 11 moInterpretomics India Private Limited
Amrith Prasad
DIN 02220047
Director01 Jul 201313 yrs 4 moInterpretomics India Private Limited
Somaprasad Muttael Prabhakaran
DIN 02217575
Director01 Jul 201313 yrs 4 moInterpretomics India Private Limited
Jamshed Dara Parakh
DIN 06872142
Director23 Jul 201412 yrs 3 moInterpretomics India Private Limited
Prashant Priya
DIN 03094896
Director23 Jul 201412 yrs 3 moInterpretomics India Private Limited

People of InterpretOmics

2 people are tracked at InterpretOmics (2 in leadership); the tracked headcount is 56.

NameRoleGroup
Co-FounderLeadership
Archana Prahlad
Co-FounderLeadership
Premium access

Complete people profiles for InterpretOmics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of InterpretOmics

Figures of Interpretomics India Private Limited, the primary company behind InterpretOmics, for FY 2016. Revenue was ₹1.20 Cr (+52% year on year). Net loss was -₹5.37 Cr (-446% margin). EBITDA was -₹4.60 Cr (-382% margin).

  • ₹1.20 CrRevenue · FY 2016 · +52% YoY
  • -₹5.37 CrNet loss · -446% margin
  • -₹4.60 CrEBITDA · -382% margin
  • ₹1.17 CrPaid-up capital
  • 56Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Interpretomics India Private Limited are on its company page.

Premium access

Detailed financial statements for InterpretOmics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of InterpretOmics

4 dated milestones of InterpretOmics across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded InterpretOmics is founded.
  2. Funding First funding round of $1.6M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $293K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Interpretomics

Premium access

Complete news archive for InterpretOmics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about InterpretOmics

InterpretOmics was founded in 2009 and raised its 1st funding round 4 years after it was founded.

InterpretOmics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

InterpretOmics is a funded company, having raised a total of $1.92M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.63M, raised on Aug 2013.

InterpretOmics has 56 employees.

The primary company behind InterpretOmics, Interpretomics India Private Limited, reported revenue of β‚Ή1.20 Cr for FY 2016, up 52% year on year.

InterpretOmics is an integrated genomics company providing genome-scale data analysis and interpretation product and services. The company utilizes public and proprietary databases to analyze data and interpret results. Its enterprise level genomics data analysis platform iOMICS allows researchers to analyze DNA and identify diagnostic markers that indicate disease. Omnia is a platform which provides users access to genetic data sets across a board range of disease indications. The company has also introduced GeneComplete is an NGS-based genetic test to confirm or determine the presence of disease in an individual, suspected of having a disease. It is also working on Preimplantation genetic screening (PGS) - a microarray-based powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities and Hotspot Cancer Mutation Screening. The company also offers genetic counseling services under the umbrella of AlphaLife using genetic and biochemical tests. It has processed about 35 TB of genomics data over 40 projects for clients including Delaware State University (DSU) and AIIMS. Singapore-based shipping company, Amarante is an investor in the company.

InterpretOmics offers ELISA Kits, Recombinant Proteins, and Expression Vectors.

InterpretOmics has 3 investors. Key investors include Amarante Shipping, Somaprasad Muttael Prabhakaran, and Prashant Priya.

The valuation of InterpretOmics is $7.33M as of Jan 2017.

InterpretOmics operates through Interpretomics India Private Limited.

The legal entities of InterpretOmics currently have 5 directors, including Jamshed Dara Parakh, Prahalad Haldhoderi Achutharao, Prashant Priya and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available